RESUMO
Photoactivatable Pt(IV) prodrugs represent nowadays an intriguing class of potential metal-based drugs, endowed with more chemical inertness in their oxidized form and better selectivity for the target with respect to the clinically established Pt(II) compounds. In fact, they have the possibility to be reduced by light irradiation directly at the site of interest. For this reason, we synthesized a new Pt(IV) complex, [Pt(OCOCH3)3(4'-phenyl-2,2':6',2''-terpyridine)][CF3SO3] (1), that is well soluble in aqueous medium and totally unreactive towards selected model biomolecules until its reduction. The highlight of this work is the rapid and efficient photoreduction of 1 with visible light (460 nm), which leads to its reactive Pt(II) analogue. This behavior was made possible by taking advantage of an efficient catalytic system based on flavin and NADH, which is naturally present in the cellular environment. As a comparison, the reduction of 1 was also studied with simple UV irradiation, but both UV-Vis spectrophotometry and 1H-NMR spectrometry showed that the flavin-catalyzed reduction with visible light was faster. Lastly, the reactivity against two representative biological targets, i.e., human serum albumin and one monofilament oligonucleotide fragment, was evaluated by high-resolution mass spectrometry. The results clearly pointed out that the prodrug 1 did not interact with these targets until its photoreduction to the Pt(II) analogue.
Assuntos
Antineoplásicos , Pró-Fármacos , Humanos , Antineoplásicos/química , Compostos Organoplatínicos/química , Luz , Espectroscopia de Ressonância Magnética , Pró-Fármacos/químicaRESUMO
Au(PEt3)I (AF-I hereafter), the iodide analog of the FDA-approved drug auranofin (AF hereafter), is a promising anticancer agent that produces its pharmacological effects through interaction with non-genomic targets such as the thioredoxin reductase system. AF-I is endowed with a very favorable biochemical profile showing potent in vitro cytotoxic activity against several cancer types including ovarian and colorectal cancer. Remarkably, in a recent publication, some of us reported that AF-I induces an almost complete and rapid remission in an orthotopic in vivo mouse model of ovarian cancer. The cytotoxic potency does not bring about highly severe side effects, making AF-I very well-tolerated even for higher doses, even more so than the pharmacologically active ones. All these promising features led us to expand our studies on the mechanistic aspects underlying the antitumor activity of AF-I. We report here on an integrated experimental and theoretical study on the reactivity of AF-I, in comparison with auranofin, toward relevant aminoacidic residues or their molecular models. Results point out that the replacement of the thiosugar moiety with iodide significantly affects the overall reactivity toward the amino acid residues histidine, cysteine, methionine, and selenocysteine. Altogether, the obtained results contribute to shed light into the enhanced antitumoral activity of AF-I compared with AF.
RESUMO
A silver(I) and a gold(I) complex of the fluorescent N-heterocyclic carbenic (NHC) ligand 1-(9-anthracenylmethyl)-3-(3-trimethylsilyl-2-propynil)-benzimidazol-2-ylidene have been synthesized and characterized. These compounds show cytotoxicity in the micromolar range and higher antiproliferative properties than cisplatin (CDDP) against several tumour cell lines such as SW480 (colon), A549 (lung) and HepG2 (liver). Both metal complexes are successfully internalized by SW480 cells being the silver compound the most accumulated. Subsequently, they were evaluated as inhibitors of the selenoenzyme Thioredoxin reductase (TrxR) and as DNA binders. Fluorescence microscopy confirmed that both protein and DNA binding could be involved in the biological activity of the compounds. The silver carbene was the most effective enzyme inhibitor with an IC50 in the nanomolar range. Also, interaction studies with natural double stranded DNA highlight a strong stabilisation of the double helix after binding to the Ag(I) carbene, indicating its potential suitability as dual-targeting anticancer active molecule.
Assuntos
Complexos de Coordenação , Citotoxinas , DNA de Neoplasias , Inibidores Enzimáticos , Ouro , Prata , Tiorredoxina Dissulfeto Redutase , Células A549 , Animais , Bovinos , Complexos de Coordenação/química , Complexos de Coordenação/farmacologia , Citotoxinas/química , Citotoxinas/farmacologia , DNA de Neoplasias/química , DNA de Neoplasias/metabolismo , Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , Ouro/química , Ouro/farmacologia , Células Hep G2 , Humanos , Metano/análogos & derivados , Metano/química , Metano/farmacologia , Ratos , Prata/química , Prata/farmacologia , Tiorredoxina Dissulfeto Redutase/antagonistas & inibidores , Tiorredoxina Dissulfeto Redutase/química , Tiorredoxina Dissulfeto Redutase/metabolismoRESUMO
The use of Pt(iv) complexes as potential anticancer drugs is attractive, because they have higher stability and less side effects than Pt(ii) compounds. Moreover, some Pt(iv) complexes can also be activated with light, opening an avenue to photochemotherapy. Our purpose is to widen the library of photoactivatable Pt(iv)-based prodrugs and here we report on the oxidation of the Pt(ii) compound [PtCl(4'-phenyl-2,2':6',2''-terpyridine)][CF3SO3] (1) with PhICl2 or H2O2. The synthetic procedure avoids the formation of multiple species: the treatment with PhICl2 produces the Pt(iv) complex with axial chlorides, [PtCl3(4'-phenyl-2,2':6',2''-terpyridine)][CF3SO3] (2), while H2O2 oxidation and post-synthesis carboxylation produce [Pt(OCOCH3)2Cl(4'-phenyl-2,2':6',2''-terpyridine)][CF3SO3] (3), bearing acetates in the axial positions. 2 and 3 are stable in physiological-like buffers and in DMSO in the dark, but undergo photoreduction to 1 upon irradiation at 365 nm. Their stability toward reduction is a fundamental parameter to consider: cyclic voltammetry experiments show that the 2 electron reduction Pt(iv) â Pt(ii) occurs at a more negative potential for 3, because of the greater stabilization provided by the acetate axial groups; noteworthily, 3 is stable for hours also in the presence of mM concentration of glutathione. The cytotoxicity of 2 and 3 toward A2780 and A2780cis cell lines reveals that 3 is the least toxic in the dark, but is able to produce cytotoxic effects far higher than cisplatin when irradiated. To shed light on the mechanistic aspects, the interaction with protein and DNA models has been explored through high-resolution mass spectrometry revealing that 2 and 3 behave as prodrugs, but are able to bind to biological targets only after irradiation.
Assuntos
Antineoplásicos/química , Antineoplásicos/farmacologia , Luz , Compostos Organoplatínicos/química , Compostos Organoplatínicos/farmacologia , Animais , Antineoplásicos/metabolismo , Linhagem Celular Tumoral , DNA/metabolismo , Humanos , Compostos Organoplatínicos/metabolismoRESUMO
A series of organometallic AuI N-heterocyclic carbene (NHC) complexes was synthesized and characterized for anticancer activity in four human cancer cell lines. The compounds' toxicity in healthy tissue was determined using precision-cut kidney slices (PCKS) as a tool to determine the potential selectivity of the gold complexes exâ vivo. All evaluated compounds presented cytotoxic activity toward the cancer cells in the nano- or low micromolar range. The mixed AuI NHC complex, (tert-butylethynyl)-1,3-bis-(2,6-diisopropylphenyl)imidazol-2-ylidene gold(I), bearing an alkynyl moiety as ancillary ligand, showed high cytotoxicity in cancer cells inâ vitro, while being barely toxic in healthy rat kidney tissues. The obtained results open new perspectives toward the design of mixed NHC-alkynyl gold complexes for cancer therapy.
Assuntos
Antineoplásicos/química , Antineoplásicos/farmacologia , Compostos Heterocíclicos/química , Compostos Heterocíclicos/farmacologia , Compostos Organoáuricos/química , Compostos Organoáuricos/farmacologia , Animais , Antineoplásicos/toxicidade , Linhagem Celular Tumoral , Compostos Heterocíclicos/toxicidade , Humanos , Rim/efeitos dos fármacos , Masculino , Metano/análogos & derivados , Metano/química , Metano/farmacologia , Metano/toxicidade , Neoplasias/tratamento farmacológico , Compostos Organoáuricos/toxicidade , Ratos WistarRESUMO
The trinuclear platinum cluster [Pt3(µ-PBut2)3(CO)3]CF3SO3 (I) was designed featuring the presence of a nearly equilateral platinum triangle bridged by three di-tert-butylphosphide ligands; in addition, each platinum center bears a terminal carbonyl ligand. This triplatinum cluster was initially developed in view of applications in the field of cluster-containing innovative materials. Yet, due to the large success of platinum complexes in cancer treatment, we also decided to explore its cytotoxic and anticancer properties. Accordingly, the solubility profile of this compound in several solvents was preliminarily investigated, revealing a conspicuous solubility in DMSO and DMSO/buffer mixtures; this makes the biological testing of I amenable. UV-Vis measurements showed that the triplatinum cluster is stable for several hours under a variety of conditions, within aqueous environments. No measurable reactivity was observed for I toward two typical model proteins, i.e. lysozyme and cytochrome c. On the contrary, a significant reactivity was evidenced when reacting I with small sulfur-containing ligands. In particular, a pronounced reactivity with reduced glutathione and cysteine emerged from ESI-MS experiments, proving complete formation of I-GSH and I-Cys derivatives, with the loss of a single carbonyl ligand. Starting from these encouraging results, the cytotoxic potential of I was assayed in vitro against a panel of representative cancer cell lines, and potent cytotoxic properties were disclosed. Of particular interest is the finding that the triplatinum species manifests potent antiproliferative properties toward Triple Negative Breast Cancer Cells, often refractory to most anticancer drugs. Owing to the reported encouraging results, a more extensive biological and pharmacological evaluation of this Pt cluster is now warranted to better elucidate its mode of action.
Assuntos
Antineoplásicos , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/metabolismo , Compostos Organoplatínicos , Antineoplásicos/síntese química , Antineoplásicos/química , Antineoplásicos/farmacologia , Neoplasias da Mama/patologia , Ensaios de Seleção de Medicamentos Antitumorais , Feminino , Células HL-60 , Humanos , Células MCF-7 , Compostos Organoplatínicos/síntese química , Compostos Organoplatínicos/química , Compostos Organoplatínicos/farmacologiaRESUMO
Several mono- or bis-alkynyl derivatives of general formula Pt6(µ-PBu(t)2)4(CO)4X(C[triple bond, length as m-dash]C-R), Pt6(µ-PBu(t)2)4(CO)4(C[triple bond, length as m-dash]C-R)2 or Pt6(µ-PBu(t)2)4(CO)4(C[triple bond, length as m-dash]C-R)(C[triple bond, length as m-dash]C-R') were obtained under Sonogashira type conditions. The new clusters have been characterized with microanalysis and using IR and multinuclear NMR spectroscopy. The crystal and molecular structures of Pt6(µ-PBu(t)2)4(CO)4(C[triple bond, length as m-dash]C-R)2 (R = H, C6H4-4-n-C5H11) are presented and electrochemical and spectroelectrochemical studies of some representative compounds are also reported.
RESUMO
Two novel gold carbene compounds, namely, chlorido (1-butyl-3-methyl-imidazole-2-ylidene) gold(I) (1) and bis(1-butyl-3-methyl-imidazole-2-ylidene) gold(I) (2), were prepared and characterized as prospective anticancer drug candidates. These compounds consist of a gold(I) center linearly coordinated either to one N-heterocyclic carbene (NHC) and one chloride ligand (1) or to two identical NHC ligands (2). Crystal structures were solved for both compounds, the resulting structural data being in good agreement with expectations. We wondered whether the presence of two tight carbene ligands in 2 might lead to biological properties distinct from those of the monocarbene complex 1. Notably, in spite of their appreciable structural differences, these two compounds manifested similarly potent cytotoxic actions in vitro when challenged against A2780 human ovarian carcinoma cells. In addition, both were able to overcome resistance to cisplatin in the A2780R line. Solution studies revealed that these gold carbene complexes are highly stable in aqueous buffers at physiological pH. Their reactivity with proteins was explored: no adduct formation was detected even upon a long incubation with the model proteins cytochrome c and lysozyme; in contrast, both compounds were able to metalate, to a large extent, the copper chaperone Atox-1, bearing a characteristic CXXC motif. The precise nature of the resulting gold-Atox-1 adducts was elucidated through ESI-MS analysis. On the basis of these findings, it is proposed that the investigated gold(I) carbene compounds are promising antiproliferative agents warranting a wider pharmacological evaluation. Most likely these gold compounds produce their potent biological effects through selective metalation and impairment of a few crucial cellular proteins.
Assuntos
Antineoplásicos/química , Complexos de Coordenação/química , Ouro/química , Metano/análogos & derivados , Antineoplásicos/síntese química , Antineoplásicos/farmacologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Complexos de Coordenação/síntese química , Complexos de Coordenação/farmacologia , Feminino , Humanos , Metano/química , Estrutura Molecular , Neoplasias Ovarianas/tratamento farmacológicoRESUMO
The monochloro derivative {Pt3}Cl [(1), {Pt3} = Pt3(µ-PBu(t)2)3(CO)2] was reacted with one equiv. of 4-ethynylbenzaldehyde under Sonogashira dehydrohalogenation conditions to afford {Pt3}CC-(1,4)C6H4-CHO, (3). Under analogous conditions, the condensation of the dichloride {Pt6}Cl2 [(2), {Pt6} = Pt6(µ-PBu(t)2)4(CO)4] with two equiv. of 4-ethynyl-benzaldehyde provided {Pt6}(CC-(1,4)C6H4-CHO)2, (4). The fulleropyrrolidine derivatives {Pt3}CC-(1,4)C6H4-C2H3N(C8H17)C60, (5), and {Pt6}(CC-(1,4)C6H4-C2H3N(C8H17)C60)2, (6), were obtained by reacting the formyl clusters 2 and 4 with an appropriate amount of N-octylglycine and C60. Cyclovoltammetric and IR, UV and NIR spectroelectrochemical data suggest the absence of a significant communication between the cluster and the fullerene units in covalent assemblies 5 and 6. The crystal and molecular structure of compound 3 is also reported.
RESUMO
Triangular clusters containing a [M3(µ-PR2)3](+) core are very common in platinum chemistry but were virtually unknown for M = Pd. Herein we describe the synthesis and characterization of several palladium derivatives belonging to this class. The trinuclear monohalide clusters {Pd3}(CO)2X [{Pd3} = Pd3(µ-PBu(t)2)3; X = Br, I] were prepared by reacting [(n)Bu4N]X or KX with the dinuclear complex [Pd(PBu(t)2H)(µ-PBu(t)2)]2 and H2O under an atmosphere of CO. The reaction of {Pd3}(CO)2I with CNBu(t) leads to the substitution of all the terminal ligands to afford the symmetrical cluster [{Pd3}(CNBu(t))3]I. The latter reacts with TlPF6 (excess) or AgCF3SO3 (1:1 ratio) to give anion metathesis, whereas the addition of a second equivalent of Ag(+) causes cluster oxidation to the thermally stable paramagnetic 43e(-) dication [{Pd3}(CNBu(t))3](2+). The cationic clusters [{Pd3}(CO)2(L)]PF6 (L = NCCH3, Py or CO) were obtained by reacting {Pd3}(CO)2I with TlPF6, under nitrogen in acetonitrile or in pyridine or under 1 atm of carbon monoxide in THF. Finally, {Pd3}(CO)2Cl was achieved by the reaction of [{Pd3}(CO)3]PF6 with [(PPh3)2N]Cl. All clusters have been obtained in good yields and purity and have been characterized by microanalysis and IR and multinuclear NMR spectroscopy. Single crystal X-ray diffraction studies on {Pd3}(CO)2Br and [{Pd3}(CNBu(t))3]CF3SO3 are also reported. The cyclovoltammetric profile exhibited by the palladium clusters prepared in this work is characterized by the presence of two monoelectronic oxidation processes whose reversibility and potentials depend on the nature of the ligands. Moreover, the UV-vis and IR spectroelectrochemical analysis of {Pd3}(CO)2I, [{Pd3}(CO)3]PF6 and [{Pd3}(CNBu(t))3]PF6 allowed the spectroscopical characterization of some electrogenerated oxidized species and provided some detail for the redox-coupled reactions of metastable products.
RESUMO
The hexanuclear phosphido-bridged dication [Pt6(µ-PBu(t)2)4(CO)6](2+), (1)(2+), reacts under mild conditions with pseudo-halide anions (CN(-), NCO(-), NCS(-)) to afford the corresponding neutral bis-substituted clusters Pt6(µ-PBu(t)2)4(CO)4X2 (2, X = CN; 3, X = SCN; 4, X = NCO). The reaction with sodium azide affords 4, which may arise from the formation of the intermediate bis-azido derivative Pt6(µ-PBu(t)2)4(CO)4(N3)2, 5, and CO. These react rapidly with each other affording 4 and N2. Cluster 5 was alternatively prepared as a stable compound by reacting with NaN3 the neutral cluster Pt6(µ-PBu(t)2)4(CO)4(OTf)2, 14, which contains two weakly bonded triflate anions. As expected, 5 reacts with carbon monoxide (1 atm) affording cluster 4 instantaneously and quantitatively. The new pseudo-halide clusters 2-5, which are interesting potential precursors of cluster-containing molecular frameworks, have been characterized by IR and multinuclear NMR spectroscopy. The solid state structures of clusters 2-4 have also been studied by single-crystal X-ray diffractometry. The main features of the molecular structures remain similar to those of many related congeners described previously; in addition, an interesting reversible phase transition was observed in the crystal structure of cluster 3. As their known congeners, the clusters undergo two reversible one-electron reductions and an irreversible oxidation. An excellent linear correlation was found between the redox potentials of the cathodic processes and Lever's ligand parameter E(L).
RESUMO
This paper presents the synthesis and structural characterization of the unprecedented tris-phosphido-bridged compounds Pt3(µ-PBu(t)2)3X3 (X = Cl, Br, I), having only 42 valence electrons, while up to now analogous clusters typically have 44e(-). The new species were obtained by an apparent bielectronic oxidation of the 44e(-) monohalides Pt3(µ-PBu(t)2)3(CO)2X with the corresponding dihalogen X2. Their X-ray structures are close to the D3h symmetry, similarly to the 44e(-) analogues with three terminal carbonyl ligands. The products were also obtained by electrochemical oxidation of the same monohalides in the presence of the corresponding halide. In a detailed study on the formation of Pt3(µ-PBu(t)2)3I3, the redox potentials indicated that I2 can only perform the first monoelectronic oxidation but is unsuited for the second one. Accordingly, the 43e(-) intermediate [Pt3(µ-PBu(t)2)3(CO)2I](+) was ascertained to play a key role. Another piece of information is that, together with the fully oxidized product Pt3(µ-PBu(t)2)3I3, the transient 44e(-) species [Pt3(µ-PBu(t)2)3(CO)3](+) is formed in the early steps of the reaction. In order to extract detailed information on the formation pathway, involving both terminal ligand substitutions and electron transfer processes, a DFT investigation has been performed and all the possible intermediates have been defined together with their associated energy costs. The profile highlights many important aspects, such as the formation of an appropriate couple of 43e(-) intermediates having different sets of terminal coligands, and suitable redox potentials for the transfer of one electron. Optimizations of 45e(-) associative intermediates in the ligand substitution reactions indicate their possible involvement in the redox process with reduction of the overall energy cost. Finally, according to MO arguments, the unique stability of the 42e(-) phosphido-bridged Pt3 clusters can be attributed to the simultaneous presence of three terminal halides.
RESUMO
The hexanuclear cluster {Pt(6)}H(2) (2) contains a sterically hindered and chemically stable {Pt(6)} = Pt(6)(mu-PtBu(2))(4)(CO)(4) core, with the six metals forming an edge-bridged tetrahedron. The two hydrides are the reactive sites of the cluster and lie on opposite sides of the cluster, terminally bonded to the two "apical" edge-bridging platinum centres. Indeed, cluster 2 reacts with acids of different acidity (HA = CF(3)SO(3)H, HBF(4), p-CH(3)-C(6)H(4)-SO(3)H, CF(3)COOH, PhCOOH and CH(3)COOH), affording, after evolution of two equivalents of dihydrogen, the corresponding anion-substituted clusters {Pt(6)}A(2) (4). We suggest that the reaction proceeds through a mechanism similar to the one generally accepted for the analogous protonation of mononuclear hydrides, with some of the intermediates partially characterised at low temperature. Interestingly, the reverse reaction, the heterolytic splitting of H(2) by clusters 4, occurs readily under mild conditions. The anions in clusters 4a and 4b (4a: A = CF(3)SO(3), 4b: A = BF(4)) are bonded in the solid state but very easily dissociate in solution and may be substituted under mild conditions by weak ligands, such as CH(2)Cl(2) or CH(3)CN. With dialkyl ethers, the reaction proceeds further with the heterolytic splitting of a C-H bond of the ethereal ligand. This process allowed us to isolate the polymer [{Pt(6)}(CH(2)OCH(2)CH(2)OCH(2))](x) (8), in which the {Pt(6)} cluster units are connected by insulating spacers arising from dimethoxyethane. The results of single-crystal X-ray diffraction studies on 4a and 8 are also reported.
RESUMO
A series of newly designed (glycerol)borate based ionic liquids were synthesized and characterized. The synthesis of these ionic liquids involves, first, the preparation of the bis(glycerol)boric acid(s) followed by neutralization with the appropriate base, [cat]OH. Ionic liquids bearing inorganic (Li(+), Na(+), K(+)) or organic cations have been prepared and characterized. The ability of the bis(glycerol)borate anions to undergo dissociation reaction in the presence of water, depending on cation nature, was investigated by NMR. Theoretical calculations were also performed to evaluate the relative stability of the possible bis(glycerol)borate isomers as nude ions or as ion pairs with Li(+), Na(+), and H(+). Important information about the structural features of H[Gly(2)B] useful to rationalize the chemical behavior have been obtained.
RESUMO
The CuI catalyzed dehydro-halogenation of 1',1'''-diethynylbiferrocene and {Pt(3)}Cl [{Pt(3)} = Pt(3)(mu-PBu(t)(2))(3)(CO)(2)] (1:2 molar ratio) in diethylamine gives in high yields the bicluster derivative [{Pt(3)}CC-(eta(5)-C(5)H(4))Fe(eta(5)-C(5)H(4))](2), 3, in which two platinum triangles are connected by a diethynylbiferrocene spacer. In the structure of 3, confirmed by a diffractometric study, the two {Pt(3)} fragments lie, perfectly eclipsed, on the same side of the biferrocenyl moiety; this folded structure is also preferred in solution, as suggested by NMR Diffusion Ordered Spectroscopy (DOSY) and 1D Rotating-frame Overhauser Enhancement (ROE) measurements. Compound 3 exhibits a rich redox behavior, with a crowded sequence of six one-electron oxidation processes, the electrode potentials of which have been evaluated by digital simulations. On the basis of a spectroelectrochemical study, the first two oxidations are assigned to the iron centers of the diferrocenyl unit and the subsequent four electrons are removed from the {Pt(3)} units.
RESUMO
The reaction between Pt(3)(mu-PBu(t)(2))(3)(CO)(2)Cl (2) and ethynylferrocene, in the presence of catalytic amounts of CuI, gives Pt(3)(mu-PBu(t)(2))(3)(CO)(2)C[triple bond]CFc (1), characterized by X-ray crystallography and representing a rare example of the sigma-coordination of an alkynyl moiety to a cluster unit. In a dichloromethane (CH(2)Cl(2)) solution, compound 1 undergoes three consecutive one-electron oxidations, the first of which is assigned to the ferrocene-centered Fe(II)/Fe(III) redox couple. Spectroelectrochemistry, carried out on a solution of 1, shows the presence of a broad band in the near-IR region, growing after the electrochemical oxidation, preliminarily associated with a metal-to-metal charge transfer toward the Fe(III) ion of the ferrocenium unit. Density functional theory (DFT) has been employed to analyze the ground- and excited-state properties of 1 and 1(+), both in the gas phase and in a CH(2)Cl(2) solution. Vertical excitation energies have been computed by the B3LYP hybrid functional in the framework of the time-dependent DFT approach, and the polarizable continuum model has been used to assess the solvent effect. Our results show that taking into account the medium effects together with the choice of an appropriate molecular model is crucial to correctly reproducing the excitation spectra of such compounds. Indeed, the nature of the substituents on P atoms has been revealed to have a key role in the quality of the calculated spectra.
RESUMO
Reaction of [Pt(6)(CO)(4)(P(t)Bu(2))(4)Cl(2)] with excess HS(CH(2))(4)SH in Et(2)NH gave highly stable [Pt(6)(CO)(4)(P(t)Bu(2))(4){S(CH(2))(4)SH}(2)], which adsorbs unchanged onto gold surfaces. This permitted the fabrication and electrical characterisation of gold|molecule|gold junctions involving a well-defined metal carbonyl cluster compound.
Assuntos
Platina/química , Ouro/química , Substâncias Macromoleculares , Estrutura Molecular , Nanofios/química , Propriedades de SuperfícieRESUMO
Useful synthons containing the tribridged triangular unit {Pt(3)} = [Pt(3)(mu-P(t)Bu(2))(3)](+) were prepared starting from the known tricarbonyl derivative [{Pt(3)}(CO)(3)]Z, [(1(+))Z, Z = CF(3)SO(3)(-)]. This was easily converted into the monohalides {Pt(3)}(CO)(2)X [2, X = Cl; 3, X = Br; 4, X = I], by reaction with the appropriate halide salt. The coupling reaction between 2 and terminal alkynes in the presence of CuI afforded in good yields the sigma-alkynyl derivatives {Pt(3)}(CO)(2)(CC-R) [6, R = SiMe(3); 7, R = CC-SiMe(3); 8, R = C(6)H(5); 9, R = C(6)H(4)-4-Br; 10, R = C(6)H(4)-4-CCH; 11, R = 2-C(4)H(2)S-5-CCH; 12, R = 9-C(14)H(8)-10-CCH], while desilylation of 6 or 7 with TBAF/THF gave, respectively, the derivatives 13 (R = H) and 14 (R = CCH). The stepwise elongation of the arylalkynyl chain was obtained by the Sonogashira coupling of 10 with an excess of 1,4-diiodobenzene, which produced 15 (R = C(6)H(4)-4-CC-C(6)H(4)-4-I), and by coupling the latter with an excess of 1,4-diethynylbenzene, which formed 16 (R = [C(6)H(4)-4-CC](3)H). Branched synthons were obtained by substitution of the carbonyl ligands with functional isocyanides; the reaction of an excess of CN-C(6)H(4)-4-R (R = I, CCH) with {Pt(3)}(CO)(2)H, 5, or with complex (1(+))Z afforded, respectively, {Pt(3)}(CN-C(6)H(4)-4-I)(2)H, 17, or [{Pt(3)}(CN-C(6)H(4)-4-R)(3)]Z [(18(+))Z, R = I; (19(+))Z, R = CCH]. The crystal structures of complexes 2, 8, and 9 were established by X-ray diffraction studies. The electrochemical characterization of representative examples of the clusters prepared in this work shows that all clusters are characterized by the presence of two oxidations; an analysis of ligands' effects on the redox processes is also included.
RESUMO
The previously reported hexanuclear cluster [Pt(6)(mu-PtBu(2))(4)(CO)(6)](2+)[Y](2) (1-Y(2): Y=CF(3)SO(3) (-)) contains a central Pt(4) tetrahedron bridged at each of the opposite edges by another platinum atom; in turn, four phosphido ligands bridge the four Pt-Pt bonds not involved in the tetrahedron, and, finally, one carbonyl ligand is terminally bonded to each metal centre. Interestingly, the two outer carbonyls are more easily substituted or attacked by nucleophiles than the inner four, which are bonded to the tetrahedron vertices. In fact, the reaction of 1-Y(2) with 1 equiv of [nBu(4)N]Cl or with an excess of halide salts gives the monochloride [Pt(6)(mu-PtBu(2))(4)(CO)(5)Cl](+)[Y], 2-Y, or the neutral dihalide derivatives [Pt(6)(mu-PtBu(2))(4)(CO)(4)X(2)] (3: X=Cl; 4: X=Br; 5: X=I). Moreover, the useful unsymmetrically substituted [Pt(6)(mu-PtBu(2))(4)(CO)(4)ICl] (6) was obtained by reacting equimolar amounts of 2 and [nBu(4)N]I, and the dicationic derivatives [Pt(6)(mu-PtBu(2))(4)(CO)(4)L(2)](2+)[Y](2) (7-Y(2): L=(13)CO; 8-Y(2): L=CNtBu; 9-Y(2): L=PMe(3)) were obtained by reaction of an excess of the ligand L with 1-Y(2). Weaker nitrogen ligands were introduced by dissolving the dichloride 3 in acetonitrile or pyridyne in the presence of TlPF(6) to afford [Pt(6)(mu-PtBu(2))(4) (CO)(4)L(2)](2+)[Z](2) (Z=PF(6) (-), 10-Z(2): L=MeCN; 11-Z(2): L=Py). The "apical" carbonyls in 1-Y(2) are also prone to nucleophilic addition (Nu(-): H(-), MeO(-)) affording the acyl derivatives [Pt(6)(mu-PtBu(2))(4)(CO)(4)(CONu)(2)] (12: Nu=H; 13: Nu=OMe). Complex 12 is slowly converted into the dihydride [Pt(6)(mu-PtBu(2))(4)(CO)(4)H(2)] (14), which was more cleanly prepared by reacting 3 with NaBH(4). In a unique case we observed a reaction involving also the inner carbonyls of complex 1, that is, in the reaction with a large excess of the isocyanides R-NC, which form the corresponding persubstituted derivatives [Pt(6)(mu-tPBu(2))(4)(CN-R)(6)](2+)[Y](2), (15-Y(2): R=tBu; 16-Y(2) (2-): R=-C(6)H(4)-4-C triple bond CH). All complexes were characterized by microanalysis, IR and multinuclear NMR spectroscopy. The crystal and molecular structures of complexes 3, 5, 6 and 9-Y(2) are also reported. From the redox viewpoint, all complexes display two reversible one-electron reduction steps, the location of which depends both upon the electronic effects of the substituents, and the overall charge of the original complex.